{"schema_version":"secwatch.filing_event.v1","accession":"0001558370-22-012883","form_type":"8-K","ticker":"CERT","cik":"0001827090","company_name":"Certara, Inc.","filed_at":"2022-08-09T23:59:59+00:00","discovered_at":"2026-05-14T18:03:57.276280+00:00","generated_at":"2026-06-24T02:18:15.319960+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Certara Q2 revenue $82.8M (+18% YoY); guides FY22 lower on FX, regulatory softness","bullets":["Revenue $82.8M, up 18% reported or 21% constant currency; excluding Pinnacle 21, up 8% reported.","Net loss improved to $0.6M from $2.9M in Q2 2021; Adjusted EBITDA $28.0M (+9% YoY).","FY 2022 guidance adjusted lower for FX headwinds and slow regulatory services recovery.","Biosimulation revenue and bookings grew double-digit; two new software products launched.","CFO expects FX and regulatory services softness to continue in H2 2022."],"urls":{"canonical":"https://secwatch.observer/filing/0001558370-22-012883","json":"https://secwatch.observer/filing/0001558370-22-012883.json","markdown":"https://secwatch.observer/filing/0001558370-22-012883.md","text":"https://secwatch.observer/filing/0001558370-22-012883.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1827090/000155837022012883/0001558370-22-012883-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1827090/000155837022012883/cert-20220809x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-24T02:18:15.319960+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}